Latest Industry Insights
2022: The Year We Implement COVID-19 Lessons Into Practice
As we seek a better tomorrow, here are three predictions from global life science and diagnostics company, PerkinElmer, that will lead to better health outcomes.
Developing Temperature-Stable ADDomer Vaccines for Untreatable Diseases
Technology Networks spoke with Jonathan Hare, PhD, Imophoron’s Head of Immunology, to learn more about the ADDomer™ vaccine platform, the benefits of administering vaccines by a variety of administrative routes and the infectious diseases they are currently working to develop vaccines for.
Developing a Vaccine for Alzheimer’s Disease
To learn more about a universal vaccine technology and how the platform could be applied to Alzheimer's disease and other neurological indications, Technology Networks spoke with Roman Kniazev, chief executive officer at Nuravax.
Simulator Technology Can Predict Optimal Vaccine Dosing
Certara is developing biosimulation and tech-enabled approaches to help scientists answer key questions at various stages of the development pipeline, serving to inform and accelerate the path to regulatory approval. One such approach, the company’s Vaccine Simulator™, can be leveraged across different therapeutic areas to determine optimal vaccine dosing and dosing regimens for different patient cohorts.
Developing Thermostable Vaccines To Improve Accessibility Worldwide
We spoke to Ozgur Tuncer, chief executive officer of Stablepharma to find out more about the company’s thermo-stabilization technology called StablevaX™ and how it is being used as a complementary technology for COVID-19 vaccines. He also highlights the impact “fridge-free” vaccines could have more generally.
Safeguarding Viability and Efficacy of COVID-19 Vaccines: Key Considerations
Learn how a freezer inventory management software enables biobanks to seamlessly manage & track storage locations of vaccines, ensure effective cold chain management, assuring quality and safe distribution of COVID-19 vaccines.
The Antibody Test That Quantifies COVID-19 Vaccine Protection
Dr Stephen Russell explores how measuring neutralizing antibody levels can help understand how risk levels can change over time and determine optimal vaccine dosing strategies.
COVID-19: Therapeutics, Preventives and Industry Perspectives
Technology Networks had the pleasure of speaking with Ki-Sung Kwon, head of the R&D unit at Celltrion to learn more about therapeutic versus preventive strategies against COVID-19 and the company's monoclonal antibody-based therapeutic – CT-P59 – that is currently being developed against COVID-19.
A Skin Test To Measure T-Cell Immunity to SARS-CoV-2
Technology Networks recently had the pleasure of speaking to Seth Lederman, president and chief executive officer of Tonix Pharmaceuticals, to learn more about the T-cell response to SARS-CoV-2, how it compares to the antibody response and the importance of measuring it during the pandemic.
Supporting Scientists Responding to the COVID-19 Pandemic
The development and implementation of efficient tests is crucial in efforts to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).